Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glutamine for Mucositis or Esophagitis
NCT01952847Phase 3Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jul 2014
- Primary completion
- Mar 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of glutamine in oral mucositis (OM), esophagitis, sponsored by University of Texas MD Anderson Cancer Center. Started Jul 2014; status: terminated.
02
Drugs
glutamine
03
Conditions
oral mucositis (OM)esophagitis
Beyond the preview
Go deeper on NCT01952847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01952847.